Thesis: Probiotics add live bacteria and fibre feeds them in bulk. A precision bioactive does something different — a small, plant-derived molecule that reprogrammes the beneficial bacteria a person already carries.
Fi Global recently asked whether precision bioactives are the next wave of gut-health ingredients, and interviewed our co-founder Tim Mak for the piece. Here is the short version of the argument.
Why “more biotics” isn’t the whole answer
The category has leaned on two tools for years, and each has a structural ceiling. As Tim put it:
“Probiotics face challenges with manufacturing, efficacy, and gut engraftment, while fibre requires high dosages to have an effect. That is why we developed an ingredient that reprogrammes a person’s native gut flora rather than just adding new bacteria.”
The move, in his words, is “going beyond probiotics and generic fibres into bioactive compounds that enhance the gut environment.”
Reprogramme, don’t add
The gut is an anaerobic place, and many of its most useful bacteria are fragile in oxygen. Plant-derived bioactives can change that environment in their favour:
“The gut microbiome is an anaerobic environment and some of the good bacteria are really super sensitive to oxygen. They can utilise dietary antioxidants like polyphenols to neutralise harmful oxygen radicals. This process protects the bacteria, boosts their energy metabolism, and produces beneficial metabolites.”
Our lead ingredient, TRI-01, works this way — a shelf-stable, plant-derived active that induces beneficial gut bacteria at milligram doses, validated in ex-vivo human gut models. No live cells, no cold chain, no bulk fibre.
A gut-brain angle
One of the bacteria TRI-01 induces is a producer of brain- and immune-active metabolites — and, as Tim noted, “the bacteria that we are inducing is actually being advanced as a treatment for Alzheimer’s disease by a company in Korea.” That makes the ingredient a candidate for both gut health and healthy-ageing concepts. He’s careful about how far that travels:
“Because we are in nutrition not pharma, we are not making any disease prevention claims, but we are focusing on the gut-brain axis and on TRI-01’s ability to improve cognitive health via modulation of neuroactive bacteria.”
From one ingredient to a discovery engine
The point was never a single compound. Good botanicals exist; what’s missing is the map. “Excellent botanicals exist, but few are mapped against the anaerobic gut environment,” Tim said. “Trilliome adds AI-guided precision to traditional extracts, proving exactly how these molecules support resident gut bacteria.”
That mapping is the company — a discovery platform that turns one validated ingredient into a repeatable method for finding the next. It also fits how the industry actually works: “Corporate giants excel at scaling, but startups are built for agile discovery.”
Read the full interview in Fi Global → · Explore the platform →
FAQ
What is a precision bioactive? A small, plant-derived molecule that selectively supports beneficial bacteria already present in the gut — rather than delivering live cells (probiotics) or bulk substrate (fibre).
How is it different from a probiotic? It adds nothing live. It reprogrammes the native gut flora a person already carries, so there is no engraftment or cold-chain problem.
What is TRI-01? Trilliome’s lead ingredient — a shelf-stable, plant-derived active that induces beneficial gut bacteria at milligram doses, validated in ex-vivo human gut models.